FDA turmoil continues as leaders resign and face legal challenges
TL;DR Summary
The FDA is embroiled in controversy following allegations against top regulator Tidmarsh, who criticized Aurinia's lupus drug voclosporin, leading to his resignation and concerns over the agency's credibility amid claims of misconduct and mismanagement.
- FDA described as a “clown show” amid latest scandal; top drug regulator is out Ars Technica
- Despite recent turmoil at FDA, White House praises the agency's leader Politico
- F.D.A. Drug Unit Chief Resigns, and Is Sued by Drug Company The New York Times
- Day after resigning, Tidmarsh now says he’ll fight exit from FDA Endpoints News
- Director of FDA drug evaluation unit placed on leave, NYT reports Reuters
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
1 min
vs 2 min read
Condensed
88%
292 → 34 words
Want the full story? Read the original article
Read on Ars Technica